Sonia S Majri

Title: The Innovations of Sonia S Majri

Introduction

Sonia S Majri is a notable inventor based in Palo Alto, California. She has made significant contributions to the field of biotechnology, particularly in the development of interleukin-2 muteins. Her work has implications for treating autoimmune diseases, showcasing her innovative approach to medical science.

Latest Patents

Sonia holds a patent for "Partial agonists of interleukin-2." This patent includes human interleukin-2 (IL-2) muteins or variants that exhibit a decreased binding capacity for IL-2Rγ. These IL-2 muteins serve as partial agonists in applications aimed at reducing or inhibiting IL-2 and/or IL-15 functions, which can be beneficial in treating autoimmune diseases. The patent also covers nucleic acids encoding these IL-2 muteins, methods for their production, and pharmaceutical compositions that incorporate them.

Career Highlights

Sonia is affiliated with Leland Stanford Junior University, where she continues her research and development in the field of biotechnology. Her work is characterized by a commitment to advancing medical treatments through innovative scientific research.

Collaborations

Sonia collaborates with talented individuals such as Kenan Christopher Garcia and Caleb R Glassman. These partnerships enhance her research efforts and contribute to the advancement of her projects.

Conclusion

Sonia S Majri's contributions to biotechnology through her innovative patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments.